Pirl

Diabetic Drug Linked To Heart Failure

samantha severyn

The Diabetic drug Onglyza or Kombiglyze may have some serious side effects leading to this ongoing investigation.

An FDA safety review has found that two diabetic medicines containing saxagliptin and alogliptin (such as Onglyza and Kombiglyze) are linked to increasing the risk of heart failure, pancreatic cancer, and thyroid cancer. Onglyza lawyers and Kombiglyze lawyers are currently investigating the possibility of taking legal action against the drug’s manufacturers on behalf of patients who suffered heart failure after taking the diabetes drug.

 For more information please contact MyPirl at info@mypirl.com

*****A VITAL NOTE FROM THE PIRL TEAM: As we report on any medical product/medication case - NEVER STOP OR ALTER A MEDICAL PROGRAM OR COURSE OF MEDICATION WITHOUT CONSULTING YOUR(S) OR A PHYSICIAN.*****